Article Details
Retrieved on: 2024-09-30 23:48:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Treatment with bosutinib led to high response rates with a manageable safety profile in patients with CML who had previously received a TKI.
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here